158 related articles for article (PubMed ID: 33220932)
21. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility.
Koss KL; Grupp IL; Kranias EG
Basic Res Cardiol; 1997; 92 Suppl 1():17-24. PubMed ID: 9202840
[TBL] [Abstract][Full Text] [Related]
22. Protective Effects of Spermidine Against Cirrhotic Cardiomyopathy in Bile Duct-Ligated Rats.
Sheibani M; Nezamoleslami S; Mousavi SE; Faghir-Ghanesefat H; Yousefi-Manesh H; Rezayat SM; Dehpour A
J Cardiovasc Pharmacol; 2020 Sep; 76(3):286-295. PubMed ID: 32902943
[TBL] [Abstract][Full Text] [Related]
23. Contractile systolic and diastolic dysfunction in renin-induced hypertensive cardiomyopathy.
Flesch M; Schiffer F; Zolk O; Pinto Y; Rosenkranz S; Hirth-Dietrich C; Arnold G; Paul M; Böhm M
Hypertension; 1997 Sep; 30(3 Pt 1):383-91. PubMed ID: 9314421
[TBL] [Abstract][Full Text] [Related]
24. An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats.
Ceolotto G; Papparella I; Sticca A; Bova S; Cavalli M; Cargnelli G; Semplicini A; Gatta A; Angeli P
Hepatology; 2008 Dec; 48(6):1913-23. PubMed ID: 19003918
[TBL] [Abstract][Full Text] [Related]
25. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model.
Jang YO; Kim MY; Cho MY; Baik SK; Cho YZ; Kwon SO
BMC Gastroenterol; 2014 Nov; 14():198. PubMed ID: 25425284
[TBL] [Abstract][Full Text] [Related]
26. Expression patterns of cell cycle-related proteins in a rat cirrhotic model induced by CCl4 or thioacetamide.
Jeong DH; Jang JJ; Lee SJ; Lee JH; Lim IK; Lee MJ; Lee YS
J Gastroenterol; 2001 Jan; 36(1):24-32. PubMed ID: 11211207
[TBL] [Abstract][Full Text] [Related]
27. Calcium regulatory proteins and their alteration by transgenic approaches.
Dillmann WH
Am J Cardiol; 1999 Jun; 83(12A):89H-91H. PubMed ID: 10750595
[TBL] [Abstract][Full Text] [Related]
28. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
Gaskari SA; Liu H; Moezi L; Li Y; Baik SK; Lee SS
Br J Pharmacol; 2005 Oct; 146(3):315-23. PubMed ID: 16025138
[TBL] [Abstract][Full Text] [Related]
29. Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice.
Medeiros A; Rolim NP; Oliveira RS; Rosa KT; Mattos KC; Casarini DE; Irigoyen MC; Krieger EM; Krieger JE; Negrão CE; Brum PC
J Appl Physiol (1985); 2008 Jan; 104(1):103-9. PubMed ID: 17975126
[TBL] [Abstract][Full Text] [Related]
30. Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats.
Yoon KT; Liu H; Zhang J; Han S; Lee SS
Clin Mol Hepatol; 2022 Apr; 28(2):232-241. PubMed ID: 34986297
[TBL] [Abstract][Full Text] [Related]
31. Exercise training and caloric restriction prevent reduction in cardiac Ca2+-handling protein profile in obese rats.
Paulino EC; Ferreira JC; Bechara LR; Tsutsui JM; Mathias W; Lima FB; Casarini DE; Cicogna AC; Brum PC; Negrão CE
Hypertension; 2010 Oct; 56(4):629-35. PubMed ID: 20644006
[TBL] [Abstract][Full Text] [Related]
32. Cirrhotic Cardiomyopathy: The Interplay Between Liver and Cardiac Muscle. How Does the Cardiovascular System React When the Liver is Diseased?
Dourakis SP; Geladari E; Geladari C; Vallianou N
Curr Cardiol Rev; 2021; 17(1):78-84. PubMed ID: 31072296
[TBL] [Abstract][Full Text] [Related]
33. Role of Oxygen Free Radicals, Nitric Oxide and Mitochondria in Mediating Cardiac Alterations During Liver Cirrhosis Induced by Thioacetamide.
Amirtharaj GJ; Natarajan SK; Pulimood A; Balasubramanian KA; Venkatraman A; Ramachandran A
Cardiovasc Toxicol; 2017 Apr; 17(2):175-184. PubMed ID: 27131982
[TBL] [Abstract][Full Text] [Related]
34. Cirrhotic cardiomyopathy.
Zardi EM; Abbate A; Zardi DM; Dobrina A; Margiotta D; Van Tassell BW; Afeltra A; Sanyal AJ
J Am Coll Cardiol; 2010 Aug; 56(7):539-49. PubMed ID: 20688208
[TBL] [Abstract][Full Text] [Related]
35. Cirrhotic cardiomyopathy.
Møller S; Henriksen JH
J Hepatol; 2010 Jul; 53(1):179-90. PubMed ID: 20462649
[TBL] [Abstract][Full Text] [Related]
36. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance.
Wiese S; Hove JD; Bendtsen F; Møller S
Nat Rev Gastroenterol Hepatol; 2014 Mar; 11(3):177-86. PubMed ID: 24217347
[TBL] [Abstract][Full Text] [Related]
37. Silymarin Administration Attenuates Cirrhotic-induced Cardiac Abnormality in the Rats: A Possible Role of β
Bayat G; Mazloom R; Hashemi SA; Pourkhalili K; Fallah P; Shams A; Esmaeili P; Khalili A
Iran J Med Sci; 2022 Jul; 47(4):367-378. PubMed ID: 35919076
[TBL] [Abstract][Full Text] [Related]
38. Calcium handling and sarcoplasmic-reticular protein functions during heart-failure transition in ventricular myocardium from rats with hypertension.
Yoneda T; Kihara Y; Ohkusa T; Iwanaga Y; Inagaki K; Takeuchi Y; Hayashida W; Ueyama T; Hisamatsu Y; Fujita M; Hatac S; Matsuzaki M; Sasayama S
Life Sci; 2001 Nov; 70(2):143-57. PubMed ID: 11787940
[TBL] [Abstract][Full Text] [Related]
39. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis.
Wong F; Liu P; Lilly L; Bomzon A; Blendis L
Clin Sci (Lond); 1999 Sep; 97(3):259-67. PubMed ID: 10464050
[TBL] [Abstract][Full Text] [Related]
40. The role of lipophilic bile acids in the development of cirrhotic cardiomyopathy.
Zavecz JH; Battarbee HD
Cardiovasc Toxicol; 2010 Jun; 10(2):117-29. PubMed ID: 20414815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
